Directory
>
Samuel Waksal
Samuel Waksal
Chief Executive Officer | MeiraGTx
New York, New York, United States
Samuel Waksal
Summary
Samuel Waksal is a prominent immunologist and entrepreneur based in New York, recognized for his significant contributions to the biotechnology sector. He has founded multiple companies, including ImClone Systems and Kadmon Biopharmaceuticals, where he has played a pivotal role in the development of groundbreaking therapies for autoimmune diseases and cancer. With a strong academic background in immunology, he is also an influential speaker, delivering lectures globally on innovation in science and cancer biology. His expertise spans various fields including neuroscience and tumor immunology, making him a well-rounded figure in the pharmaceutical industry. Samuel's work is characterized by a commitment to advancing medical research and improving patient outcomes through innovative treatments. He has a proven track record in R&D, having developed key drugs like Erbitux and Cyramza. Samuel continues to lead initiatives that aim to cure diseases by restoring immune system homeostasis.
Samuel Waksal
Work Experience
Chief Executive Officer at
GRAVITON BIOSCIENCE LIMITED
January 2022 - Present
Chairman Chief executive Officer and President at
Graviton Biopharmaceuticals
January 2020 - Present
Visiting Fellow at
BRAIN-MIND INSTITUTE
January 2018 - Present
Visiting Fellow at
Appel Alzheimers Research Institure Weill Cornell Medicine
June 2016 - Present
Founder and founding chairman at
MeiraGTx
January 2015 - Present
Founder Equilibre Neuroscience corporation at
Equilibre Holding
June 2019 - January 2023
Founder Chairman Chief Science Innovation Strategy at
Kadmon
September 2014 - February 2016
Founder at
Kadmon
January 2010 - February 2016
Founder Chairman Chief Executive Officer at
Kadmon
January 2010 - January 2016
Founder Chairman CEO at
Kadmon
January 2010 - September 2014
Founder CEO President at
Imclone Systems
January 1985 - January 2002
Samuel Waksal
Education
The Ohio State University College of Medicine, Doctorate
Frequently Asked Questions about Samuel Waksal
What company does Samuel Waksal work for?
Samuel Waksal is a Chief Executive Officer at MeiraGTx, a company specializing in Commercial physical research.
Where Samuel Waksal graduated from?
Samuel Waksal holds a degree in Immunology from The Ohio State University College of Medicine.
Who is Samuel Waksal?
Samuel Waksal is a prominent immunologist and entrepreneur based in New York, recognized for his significant contributions to the biotechnology sector. He has founded multiple companies, including ImClone Systems and Kadmon Biopharmaceuticals, where he has played a pivotal role in the development of groundbreaking therapies for autoimmune diseases and cancer. With a strong academic background in immunology, he is also an influential speaker, delivering lectures globally on innovation in science and cancer biology. His expertise spans various fields including neuroscience and tumor immunology, making him a well-rounded figure in the pharmaceutical industry. Samuel's work is characterized by a commitment to advancing medical research and improving patient outcomes through innovative treatments. He has a proven track record in R&D, having developed key drugs like Erbitux and Cyramza. Samuel continues to lead initiatives that aim to cure diseases by restoring immune system homeostasis.
Samuel`s contact details
Colleagues
Vice President Preclinical Development
VP MSAT
Chief Operating Officer
Chief Medical Officer
Vice President, Salivary Gland Therapeutics Lead
Executive Director, CMC Regulatory Affairs
VP, Biostatistics
VP Clinical Research and Ophthalmology
Senior Vice President, Head of Business Development